Subtilase variants and compositions comprising same
AssigneeNovozymes A/S
InventorsEsben Peter Friis, Rolf Thomas Lenhard, Lars Lehmann Hylling Christensen, Carl Mikael Bauer
Life of this patent
Estimating the term…
Abstract
The invention relates to subtilase variants and detergent compositions comprising the variants, as well as methods of producing the variants and methods for stabilizing a subtilase variant.
Claims22
A subtilase variant, comprising mutations at three or more positions selected from the group consisting of 9, 63, 76, 88, 104, 107, 128, 131, 159, 204, 206, 209, 212, 215, 216, 261 and 262, wherein positions are numbered according to SEQ ID NO:
- 1, and wherein the variant has protease activity and a sequence identity to SEQ ID NO:
- 1 of at least 80% and less than 100%.
A subtilase variant, comprising the substitution L209W and at least two substitutions selected from the group consisting of S63G/A, G215A and Y217L/I/V/M, wherein positions are numbered according to SEQ ID NO:
- 1, and wherein the variant has protease activity and a sequence identity to SEQ ID NO:
- 1 of at least 80% and less than 100%.
A subtilase variant, comprising the substitutions Y104V/I/L/M+G128S/A/T, and (a) at least two mutations selected from the group consisting of S9E/D, N76D/E, I107L/V/M, G131*, G131P, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S and A216V/I/L/M, or (b) L209W and at least two substitutions selected from the group consisting of S63G/A, G215A and Y217L/I/V/M, wherein positions are numbered according to SEQ ID NO:
- 1, and wherein the variant has protease activity and a sequence identity to SEQ ID NO:
- 1 of at least 80% and less than 100%.
A subtilase variant, comprising at least three mutations selected from the group consisting of S9E/D, N76D/E, A88V/I/L/M, S159E/D, S204D/E, Q206L/I/V/M, L209W, N212G/A/S, A216V/I/L/M, Y217L/I/V/M, F261W/N/T and Y262E/D, wherein positions are numbered according to SEQ ID NO:
- 1, and wherein the variant has protease activity and a sequence identity to SEQ ID NO:
- 1 of at least 80% and less than 100%.
A method for stabilizing a subtilase variant, the method comprising introducing into a parent subtilase having protease activity and at least 80% sequence identity to SEQ ID NO:
- 1 at least three mutations selected from:
- L209W in combination with two or more substitutions selected from S63G/A, G215A and Y217L/I/V/M;
- (ii) Y104V/I/L/M and G128S/A/T in combination with at least one mutation selected from S9E/D, S63G/A, N76D/E, I107L/V/M, G131*, G131P, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, G215A, A216V/I/L/M and Y217L/I/V/M;
- (iii) S9E/D in combination with at least two substitutions selected from N76D/E, S204D/E and N212G/A/S;
- (iv) N76D/E in combination with at least two substitutions selected from S9E/D, A88V/I/L/M, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, A216V/I/L/M, F261W/N/Y and Y262E/D;
- (v) Q206L/I/V/M in combination with at least two substitutions selected from S9E/D, N76D/E, S159E/D, S204D/E, L209W/N/Y, N212G/A/S, A216V/I/L/M, Y217L/l/V/M, F261W/N/Y and Y262E/D;
- and
- (vi) S204D/E, N212G/A/S and A216V/I/L/M, preferably in combination with at least one substitution selected from S9E/D, S159E/D and Q206L/I/V/M.
A method for obtaining a subtilase variant, the method comprising (a) providing a host cell comprising a polynucleotide encoding a variant of a parent protease having three or more mutations, e.g. four or more mutations, compared to SEQ ID NO:
- 1, wherein the variant has protease activity and a sequence identity to SEQ ID NO:
- 1 of at least 80%, and wherein the mutations are selected from:
- L209W in combination with two or more substitutions selected from S63G/A, G215A and Y217L/I/V/M;
- (ii) Y104V/I/L/M and G128S/A/T in combination with at least one mutation selected from S9E/D, S63G/A, N76D/E, I107L/V/M, G131*, G131P, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, G215A, A216V/I/L/M and Y217L/I/V/M;
- (iii) S9E/D in combination with at least two substitutions selected from N76D/E, S204D/E and N212G/A/S;
- (iv) N76D/E in combination with at least two substitutions selected from S9E/D, A88V/I/L/M, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, A216V/I/L/M, F261W/N/Y and Y262E/D;
- (v) Q206L/I/V/M in combination with at least two substitutions selected from S9E/D, N76D/E, S159E/D, S204D/E, L209W/N/Y, N212G/A/S, A216V/I/L/M, Y217L/I/V/M, F261W/N/Y and Y262E/D;
- and
- (vi) S204D/E, N212G/A/S and A216V/I/L/M, preferably in combination with at least one substitution selected from S9E/D, S159E/D and Q206L/I/V/M;
- (b) cultivating the host cell under conditions suitable for expression of the variant;
- and
- (c) recovering the variant.
(canceled)
Dependencies are inferred from the claim text.